Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation.
Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, the company operates globally with 146 affiliates and more than 47,000 employees. Since its founding in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel treatments for human and veterinary medicine.
YOU ARE LEAVING BREATHLESSIPF.COM
This is a link to a website for a prescription medicine approved to treat idiopathic pulmonary fibrosis (IPF). Please click the “CONTINUE” button to proceed. If you would prefer to stay on breathlessipf.com, click the “CANCEL” button.
Our IPF support program hasn’t begun yet and is unavailable at this time. Check back soon so you can sign up for additional IPF tools, resources and support.